BeStock  
Stocks › NVAX

Novavax NVAX

US equityMarket cap rank #2749
$12.56 +$2.10 (+20.08%)
Pre-market · Oct 6, 7:40 am ET · After hours $12.45 -0.88%
Open$10.47
Prev close$10.46
Day range$10.28 – $13.39
Volume28.70M
Market cap$2.07B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-9.3x
CheapRich

Near the bottom of its 5-year range · 10th percentile, 5-year average -2.9x

Price / book-10.9x
CheapRich

Near the bottom of its 5-year range · 11th percentile, 5-year average 2.6x

P/E over five years

-28x-16x-4x7xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.25
Price vs. fair value-17.7%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -10.87 – 2.59 11% (cheaper than usual) –
PE -9.30 -14.47 -2.85 10% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$15.25
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on NVAX.

Leave a comment

Scroll to Top